Ticker > Company >

Indegene share price

Indegene Ltd.

NSE: INDGN BSE: 544172 SECTOR: Pharmaceuticals & Drugs  65k   60   32

580.50
-14.90 (-2.50%)
BSE: Today, 01:35 PM

Price Summary

Today's High

₹ 594

Today's Low

₹ 577.2

52 Week High

₹ 736.6

52 Week Low

₹ 485.15

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

13935.95 Cr.

Enterprise Value

13772.35 Cr.

No. of Shares

24.01 Cr.

P/E

76.87

P/B

7.52

Face Value

₹ 2

Div. Yield

0.34 %

Book Value (TTM)

₹  77.15

CASH

163.6 Cr.

DEBT

0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  7.55

Sales Growth

4.59%

ROE

13.07 %

ROCE

17.22%

Profit Growth

31.47 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.59%
3 Year9.34%
5 Year26.73%

Profit Growth

1 Year31.47%
3 Year10.96%
5 Year41.74%

ROE%

1 Year13.07%
3 Year15.87%
5 Year36.91%

ROCE %

1 Year17.22%
3 Year21.32%
5 Year31.33%

Debt/Equity

0

Price to Cash Flow

108.03

Interest Cover Ratio

39.4677

CFO/PAT (5 Yr. Avg.)

0.6725688589095

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 0.00 0.00
Dec 2024 0.00 0.00
Sep 2024 0.00 0.00
Jun 2024 0.00 0.00
Mar 2024 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 21.3163666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 39.4677.
  • Company has a healthy liquidity position with current ratio of 6.4274.

 Limitations

  • The company has shown a poor revenue growth of 9.33583429915583% for the Past 3 years.
  • The company is trading at a high PE of 76.87.
  • The company is trading at a high EV/EBITDA of 51.1405.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 272.5 258.6 281.7 286.7 266.7
Total Expenditure 226.1 219.1 235.3 234.8 227.1
Operating Profit 46.4 39.5 46.4 51.9 39.6
Other Income 23.1 13.7 22.4 22.3 35.2
Interest 1.5 1.5 1.6 1.6 1.5
Depreciation 7.6 6.6 6.2 6.5 6.9
Exceptional Items 0 0 0 0 0
Profit Before Tax 60.4 45.1 61 66.1 66.4
Tax 11.5 12.5 16.2 16.2 12.2
Profit After Tax 48.9 32.6 44.8 49.9 54.2
Adjusted EPS (Rs) 2.2 1.36 1.87 2.09 2.26

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 511 836.7 1005.7 1045.6 1093.6
Total Expenditure 361 668 828.1 877.6 913.1
Operating Profit 150 168.7 177.6 168 180.5
Other Income 24.5 27.8 37.1 50.3 90.4
Interest 3.5 3 6.4 6.6 6.2
Depreciation 17.6 23.6 31.7 31.1 26.2
Exceptional Items 3 0 0 0 0
Profit Before Tax 156.4 169.9 176.6 180.6 238.5
Tax 26.9 37.2 46.4 42.7 57.2
Net Profit 132.4 132.7 130.2 137.9 181.3
Adjusted EPS (Rs.) 6.85 5.27 5.88 6.21 7.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.3 0.4 44.3 44.4 47.9
Total Reserves 253.6 649.6 751 909.4 1840.3
Borrowings 0 0 0 0 0
Other N/C liabilities 7.1 48.8 59.4 53.2 50.4
Current liabilities 93.3 140.7 169.4 198.1 189.5
Total Liabilities 354.3 839.5 1024.1 1205.1 2128.1
Assets
Net Block 40.6 72 78.3 56.1 52.8
Capital WIP 0 0 0 0 3.6
Intangible WIP 0 0 0 0 0
Investments 83.4 83.4 231.5 385.4 471.3
Loans & Advances 12.3 149.5 11.1 12.5 382
Other N/C Assets 0.1 0.1 0.3 0.1 0.4
Current Assets 217.9 534.5 702.9 751 1218
Total Assets 354.3 839.5 1024.1 1205.1 2128.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 159.9 169.9 176.6 180.6 238.5
Adjustment 11.3 15.5 32.8 2.5 -40.3
Changes in Assets & Liabilities -92.3 -111.3 -85.7 42.4 1.4
Tax Paid -25.6 -35.9 -41.8 -49.3 -70.6
Operating Cash Flow 53.3 38.2 81.9 176.2 129
Investing Cash Flow -34.1 -266.9 -51 -189 -824.3
Financing Cash Flow -37.1 244.9 -16.9 -15.8 717.3
Net Cash Flow -17.9 16.2 14 -28.6 22

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 100.00 100.00 100.00 100.00 100.00
anand kiran 2.18 2.18 2.18 2.18 2.17
bpc genesis fund i a spv ... 3.26 3.26 3.26 3.26 3.25
bpc genesis fund i spv lt... 6.29 6.29 6.29 6.29 6.27
ca dawn investments 14.52 14.52 14.52 10.23 10.20
chestnut associates (ptc)... - - - - 1.43
fidelity funds - india fo... - 1.17 1.62 1.76 1.75
gaurav kapoor 2.62 2.62 2.62 2.62 2.61
llp 2.11 2.29 4.34 2.58 2.45
manish gupta 8.97 8.97 8.97 8.97 8.95
nadathur fareast pte ltd 22.03 22.03 22.03 22.03 21.96
rajesh bhaskaran nair 7.13 7.13 7.13 7.19 7.16
sanjay s parikh 5.01 5.01 5.01 5.02 5.00
sbi innovative opportunit... - - - - 1.39
smallcap world fund, inc - - 1.05 1.05 1.19
sycamore philanthropy (pt... - - - - 1.43
vida trustees private lim... - 2.34 2.34 2.34 2.33
aarabhi partners consulta... 2.11 2.11 2.11 2.11 -
chestnut associates (ptc)... - - 1.44 1.44 -
sycamore associates (ptc)... - - 1.44 1.44 -
sycamore philanthropy (pt... - 1.44 - - -
chestnut associates (ptc)... 1.44 - - - -
sycamore philanthropy (pt... 1.44 - - - -
vida trustees private lim... 2.34 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Indegene informs about analyst meet 22 May, 12:06 PM Indegene partners with Indian Institute of Cerebral Palsy 19 May, 12:20 PM Indegene informs about press release 19 May, 11:45 AM Indegene partners with Indian School of Public Policy 7 May, 11:07 AM Indegene - Quaterly Results 28 Apr, 7:48 PM Indegene - Quaterly Results 28 Apr, 7:48 PM Indegene informs about updates 24 Apr, 5:23 PM Indegene launches new center in London 20 Mar, 9:27 AM Indegene recognized among Financial Times High-Growth Companies in Asia-Pacific 2025 18 Mar, 4:43 PM Indegene informs about notice of postal ballot 17 Mar, 4:55 PM Indegene informs about press release 10 Mar, 11:39 AM Indegene launches Cortex 24 Feb, 1:00 PM Indegene informs about board meeting proceedings 24 Feb, 12:23 PM Indegene informs about press release 24 Feb, 11:48 AM Indegene informs about investor meet 20 Feb, 5:12 PM Indegene informs about board meeting 18 Feb, 5:30 PM Indegene launches new entity in Spain 6 Feb, 2:42 PM Indegene - Quaterly Results 30 Jan, 5:37 PM Indegene - Quaterly Results 30 Jan, 5:37 PM Indegene - Quaterly Results 30 Jan, 5:37 PM Indegene informs about outcome of board meeting 30 Jan, 5:31 PM Indegene informs about disclosure 23 Jan, 9:39 AM Indegene informs about press release 17 Jan, 4:26 PM Indegene informs about press release 17 Dec, 11:02 AM Indegene informs about press release 9 Dec, 9:59 AM Indegene informs about disclosures 6 Dec, 12:32 PM Indegene informs about disclosures 6 Dec, 12:31 PM Indegene informs about disclosure 5 Dec, 5:15 PM Indegene informs about disclosure 4 Dec, 2:38 PM Indegene informs about disclosure 26 Nov, 10:02 AM Indegene submits analyst meet intimation 25 Nov, 5:29 PM Indegene informs about disclosure 25 Nov, 2:04 PM Indegene unveils new center in Hyderabad 18 Nov, 2:29 PM Indegene - Quaterly Results 28 Oct, 7:04 PM Indegene - Quaterly Results 28 Oct, 7:04 PM Indegene informs about press release 10 Oct, 12:42 PM Indegene informs about Investor Meet 16 Sep, 4:20 PM Indegene informs about trading window closure 2 Aug, 2:55 PM Indegene - Quaterly Results 1 Aug, 8:05 PM Indegene - Quaterly Results 1 Aug, 8:05 PM Indegene informs about press release 11 Jul, 2:37 PM Indegene enters into strategic collaboration with Microsoft 11 Jul, 2:24 PM Indegene collaborates with Indian Institute of Science, Ignite Life Science Foundation 12 Jun, 2:45 PM Indegene informs about outcome of board meeting 30 May, 11:47 AM Indegene informs about disclosure 16 May, 2:50 PM Indegene coming with IPO to raise upto Rs 1881 crore 3 May, 3:42 PM Indegene files Rs 3,200 crore IPO papers with SEBI 16 Dec, 10:04 AM

Indegene Stock Price Analysis and Quick Research Report. Is Indegene an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Indegene and its performance over the period of time. Indegene stock price today is Rs 582.85.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Indegene cash from the operating activity was Rs 129 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Indegene has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Indegene , the EPS growth was 21.8652 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Indegene has OPM of 16.5051207022677 % which is a good sign for profitability.
     
  • ROE: Indegene have a average ROE of 13.0695 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Indegene is Rs 582.85. One can use valuation calculators of ticker to know if Indegene share price is undervalued or overvalued.
Last Updated on:
Brief about Indegene
X